CA50589/CA/NCI NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
1993	1
1994	1
1995	1
1997	1
1999	1
2000	1
2001	2
2005	1
2024	0

1

Estrogens, progestogens, normal breast cell proliferation, and breast cancer risk.

Pike MC, Spicer DV, Dahmoush L, Press MF. Pike MC, et al. Epidemiol Rev. 1993;15(1):17-35. doi: 10.1093/oxfordjournals.epirev.a036102. Epidemiol Rev. 1993. PMID: 8405201 Review.

2

Amplification and overexpression of HER-2/neu (c-erbB2) in endometrial cancers: correlation with overall survival.

Saffari B, Jones LA, el-Naggar A, Felix JC, George J, Press MF. Saffari B, et al. Cancer Res. 1995 Dec 1;55(23):5693-8. Cancer Res. 1995. PMID: 7585656

3

Correlation of p53 mutations with resistance to platinum-based chemotherapy and shortened survival in ovarian cancer.

Reles A, Wen WH, Schmider A, Gee C, Runnebaum IB, Kilian U, Jones LA, El-Naggar A, Minguillon C, Schönborn I, Reich O, Kreienberg R, Lichtenegger W, Press MF. Reles A, et al. Clin Cancer Res. 2001 Oct;7(10):2984-97. Clin Cancer Res. 2001. PMID: 11595686

4

p53 mutations and expression in ovarian cancers: correlation with overall survival.

Wen WH, Reles A, Runnebaum IB, Sullivan-Halley J, Bernstein L, Jones LA, Felix JC, Kreienberg R, el-Naggar A, Press MF. Wen WH, et al. Int J Gynecol Pathol. 1999 Jan;18(1):29-41. doi: 10.1097/00004347-199901000-00005. Int J Gynecol Pathol. 1999. PMID: 9891239

5

Comparison of TP53 mutations identified by oligonucleotide microarray and conventional DNA sequence analysis.

Wen WH, Bernstein L, Lescallett J, Beazer-Barclay Y, Sullivan-Halley J, White M, Press MF. Wen WH, et al. Cancer Res. 2000 May 15;60(10):2716-22. Cancer Res. 2000. PMID: 10825146

6

Amplification and overexpression of HER-2/neu in carcinomas of the salivary gland: correlation with poor prognosis.

Press MF, Pike MC, Hung G, Zhou JY, Ma Y, George J, Dietz-Band J, James W, Slamon DJ, Batsakis JG, et al. Press MF, et al. Cancer Res. 1994 Nov 1;54(21):5675-82. Cancer Res. 1994. PMID: 7522962

7

WAF1/Cip1 gene polymorphism and expression in carcinomas of the breast, ovary, and endometrium.

Lukas J, Groshen S, Saffari B, Niu N, Reles A, Wen WH, Felix J, Jones LA, Hall FL, Press MF. Lukas J, et al. Am J Pathol. 1997 Jan;150(1):167-75. Am J Pathol. 1997. PMID: 9006333 Free PMC article.

8

Association of p53 mutations and a codon 72 single nucleotide polymorphism with lower overall survival and responsiveness to adjuvant radiotherapy in endometrioid endometrial carcinomas.

Saffari B, Bernstein L, Hong DC, Sullivan-Halley J, Runnebaum IB, Grill HJ, Jones LA, El-Naggar A, Press MF. Saffari B, et al. Int J Gynecol Cancer. 2005 Sep-Oct;15(5):952-63. doi: 10.1111/j.1525-1438.2005.00159.x. Int J Gynecol Cancer. 2005. PMID: 16174251 Free article.

9

Alternative and aberrant messenger RNA splicing of the mdm2 oncogene in invasive breast cancer.

Lukas J, Gao DQ, Keshmeshian M, Wen WH, Tsao-Wei D, Rosenberg S, Press MF. Lukas J, et al. Cancer Res. 2001 Apr 1;61(7):3212-9. Cancer Res. 2001. PMID: 11306511

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

9 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

9 results

Results by year